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The allosteric regulator BAY 41-2272 converts the CO-
sGC enzyme from a low- to high-output form, with
respect to production of cGMP. Resonance Raman (RR)
and Fourier Transform Infrared (FTIR) spectroscopic tech-
niques are used to show that the CO adduct of sGC exists
as major and minor conformers, both having ν (Fe-CO)
and ν (C-O) modes characteristic of six coordinate spe-
cies. It is further shown that addition of BAY 41-2272 to
the CO adduct induces the transition of some fraction of
the initial CO-heme adducts into two new CO-heme com-
plexes. This fractional conversion is temperature depend-
ent. One new complex displays vibrational modes
characteristic of pentacoordinated CO-adduct and its for-
mation is not affected by temperature. The second com-
plex, although slightly different from the original CO-
adducts, is hexacoordinated and its formation is facili-
tated by temperature. The production of substantial
amounts of the five coordinate CO adduct upon addition
of BAY 41-2272, reveals the fact that several out-of-plane
heme deformation modes are simultaneously activated,
an observation similar to that realized upon NO activa-
tion. By analogy with earlier studies of other heme pro-
teins, several bands associated with modes attributable to
peripheral substituent deformations and methine carbon
movements are implicated. The documented formation of
two new forms upon addition of BAY 41-2272 (a 5-coor-
dinate and a new 6-coordinate form) is discussed with
respect to the implications for enzyme activation.
FTIR analysis of the amide I region of sGC enzyme was
used to assess conformational changes occurring upon
activation with various ligands and regulators. Difference
spectra of untreated sGC and the enzyme treated with BAY
41-2272 [sGC/BAY-sGC] or CO [sGC/CO-sGC] alone
showed only weak changes in amide I region, interpreted
as insignificant changes in protein conformation. How-
ever, comparison of conformational signatures occurring
in the amide I region upon enzyme's exposure to NO or
combined CO/BAY 41-2272 treatment showed a signifi-
cant change in the conformation. Both [sGC/NO-sGC]
and [sGC/CO/BAY-sGC] difference spectra display posi-
tive bands at 1653, 1687, 1643 and 1625 cm-1, as well as
a negative band at 1650 cm-1. These features are character-
istic of amide I modes arising from turns, α-helices and β-
sheet secondary structures. This finding suggest that sGC
enzyme in a high-output mode achieves a similar confir-
mation independently on the nature of the stimuli.
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